Beximco Pharma revenue crosses Tk5,000cr for first time, profit jumps 31%

Beximco Pharmaceuticals’ revenue crossed BDT5,000 crore for the first time in FY26, rising 15% year-on-year to BDT5,626 crore as growth in domestic sales and exports boosted earnings.

According to the pharma giant’s audited financial statements, net profit increased 31% to BDT914 crore, while earnings per share (EPS) stood at BDT20.17. Its board recommended a 60% cash dividend for the financial year.

Bxpharma

https://www.tbsnews.net/economy/stocks/beximco-pharma-revenue-crosses-tk5000cr-first-time-profit-jumps-31-1599846